MoneyWorks4Me

With no major difference for the quarter endedSeptember 2022 , the total revenue stood at Rs. 544.91  millions.Net Profit of the company move down -35.99% to Rs. 35.98  millions from Rs. 56.21 millions  in the same quarter last year.A decline of 71.62 millions was observed in the OP in the quarter ended September 2022 from 83.94 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 544.91 529.37 2.94 1058.91 1042.06 1.62 2196.63 2448.05 -10.27
Other Income 28.72 27.25 5.39 58.52 40.56 44.28 119.93 71.41 67.95
PBIDT 71.62 83.94 -14.68 136.28 167.23 -18.51 314.56 449.80 -30.07
Interest 6.18 1.20 415.00 11.22 3.09 263.11 13.55 2.71 400.00
PBDT 65.44 82.74 -20.91 125.06 164.49 -23.97 301.25 447.39 -32.67
Depreciation 11.75 9.74 20.64 21.70 19.45 11.57 39.48 40.35 -2.16
PBT 53.69 73.00 -26.45 103.36 145.04 -28.74 261.77 407.04 -35.69
TAX 17.71 16.79 5.48 28.71 34.86 -17.64 63.86 115.32 -44.62
Deferred Tax 3.51 0.12 2825.00 4.21 0.06 6916.67 1.40 2.31 -39.39
PAT 35.98 56.21 -35.99 74.65 110.18 -32.25 197.91 291.72 -32.16
Equity 940.00 829.95 13.26 940.00 829.95 13.26 862.45 789.95 9.18
PBIDTM(%) 13.14 15.86 -17.11 12.87 16.05 -19.80 14.32 18.37 -22.06
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..